Results 61 to 70 of about 12,508,548 (262)

Synergistic perspectives—How single‐molecule biophysics complement biochemical understanding

open access: yesFEBS Letters, EarlyView.
In this review, we discuss how ensemble biochemistry and single‐molecule approaches are complementary, outline commonly used single‐molecule techniques, and illustrate their relevance through two representative case studies: chromatin organization by SMC complexes and pathway choice during DNA double‐strand break repair.
Sara De Bragança   +2 more
wiley   +1 more source

Statement to the Clinical Laboratory Improvements Advisory Committee on the CLIA Regulations Assessment Workgroup [PDF]

open access: yes
The College of American Pathologists (CAP) appreciates the opportunity to provide written comments to the Clinical Laboratory Improvement Advisory Committee (CLIAC) on the Clinical Laboratory Improvements Amendments of 1988 (CLIA) Regulations Assessment ...

core  

Antimicrobial resistance in the practice of primary care physicians: infection diagnosis

open access: yesFamily Medicine & Primary Care Review
The selection of appropriate specimens for diagnostic testing constitutes a critical step in the treatment process, as the data thus generated forms the foundation for evidence-based medical decisions.
Hanna Laudy-Wiaderny, Aneta Nitsch-Osuch
doaj   +1 more source

The Shewanella oneidensis Fic enzyme SoFic targets the switch‐I region of EF‐Tu for AMPylation

open access: yesFEBS Letters, EarlyView.
Fic enzymes mediate diverse post‐translational modifications across all domains of life, including AMPylation. Prokaryotic EF‐Tu can be AMPylated and deAMPylated by the conserved Fic enzyme SoFic. Structural and biochemical approaches were used to characterize the effect of AMPylation on EF‐Tu, SoFic's enzymatic activities, and the enzyme‐target ...
Svenja Runge   +6 more
wiley   +1 more source

Clinical laboratory COVID-19 response call : March 22, 2021 [PDF]

open access: yes
CDC\u2019s Division of Laboratory Systems (DLS) convenes regular calls with clinical laboratories to discuss the nation\u2019s clinical laboratory response to coronavirus disease (COVID-19).

core  

Clinical laboratory COVID-19 response call : October 19, 2020 [PDF]

open access: yes
CDC\u2019s Division of Laboratory Systems (DLS) convenes regular calls with clinical laboratories to discuss the nation\u2019s clinical laboratory response to coronavirus disease (COVID-19).

core   +4 more sources

Routine laboratory data for predicting 30-day emergency department revisits: the AXIS-2 risk score

open access: yesBMC Emergency Medicine
Background Thirty-day emergency department (ED) revisit is a major quality indicator reflecting morbidity and healthcare burden. Laboratory data obtained during outpatient encounters may capture underlying biological stress axes.
Ferhat Demirci, Aylin Demirci
doaj   +1 more source

A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma

open access: yesFEBS Letters, EarlyView.
Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos   +9 more
wiley   +1 more source

Clinical laboratory COVID-19 response call : April 5, 2021 [PDF]

open access: yes
CDC\u2019s Division of Laboratory Systems (DLS) convenes regular calls with clinical laboratories to discuss the nation\u2019s clinical laboratory response to coronavirus disease (COVID-19).

core  

Comparative Evaluation of Three Preprocessing Methods for Extraction and Detection of Influenza A Virus Nucleic Acids from Sputum

open access: yesFrontiers in Medicine, 2018
Viscous sputum specimens usually cannot undergo automated extraction, and thus, a pre-homogenization process is desirable before isolating nucleic acids for real-time reverse transcription PCR.
Fei Yu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy